The European Union's drugs regulator on Friday rejected Eli Lilly's Alzheimer's drug, saying the treatment's small impact on ...

The EU’s medicines regulator has declined to approve Eli Lilly’s new Alzheimer’s drug, deciding the risks of serious and potentially fatal side effects outweigh the benefits of slowing progression of ...

New research identifies 16 genes linked to Alzheimer's risk while experts emphasize powerful lifestyle changes that could ...

Discover practical lifestyle changes to reduce your Alzheimer's risk and protect your brain health through diet, exercise, ...

Obesity and diabetes, more common in recent decades, could lead to more dementia, but much touted new drugs that reduce them could blunt that trend — if people can get them.

MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS), a clinical-stage biopharmaceutical company, is set to showcase significant ...

Dr. Alissa Huhn, a carrier of the Alzheimer’s risk gene, offers personalized health strategies to prevent cognitive decline ...

What’s more, in 1997 Professor Itzhaki found that people with a genetic variant known to increase Alzheimer’s risk, ApoE4, were only more likely to get the disease if they also had HSV1 in ...

Among APOE4 carriers, women had significantly faster tau deposits in the inferior-temporal region. Sex differences in tau may help explain why women face higher Alzheimer's dementia risk than men.

Despite further analyses in a subgroup of patients with no copies of the ApoE4 gene, known to have a lower risk of ARIA, the ...

The focus on the cognitive response in Parkinson’s patients and the advantages of buntanetap for APOE4 carriers addresses significant unmet needs in the treatment of Alzheimer's and Parkinson's ...